Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with preexisting cognitive impairment saw greater improvement after successful treatment.
This finding was especially pronounced among those with cirrhosis, a history of depression, liver disease progression or liver cancer.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
This is according to a survey of people living with HIV in the United Kingdom and Ireland.
This is according to a recent mathematical modeling study.
People who beat hepatitis C virus (HCV) see their health-related quality of life (HRQL) improve—and not just in the short term.
The recently approved combination tablet includes the medications glecaprevir and pibrentasvir.
A study with up to three years of follow-up found that every measure of health-related quality of life improved and remained elevated.
A recent economic analysis sheds light on whether averting hep C–driven severe liver disease through treatment is worth the expense.
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
Injection drug users who are cured of hepatitis C experience a raised quality of life but remain at risk of contracting the virus again.
It is so important for all of us with hep C to get cured, so we can continue to enjoy quality of life.
Interferon, along with depression and fatigue, is an independent variable that dampens the experience of hepatitis C treatment.
Much attention is focused on the effort to achieve a cure for hepatitis C. But what actually happens after the virus is finally gone?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.